A detailed history of Vanguard Group Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Group Inc holds 13,430,456 shares of IONS stock, worth $505 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,430,456
Previous 14,203,481 5.44%
Holding current value
$505 Million
Previous $719 Million 18.97%
% of portfolio
0.01%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$42.03 - $53.55 $32.5 Million - $41.4 Million
-773,025 Reduced 5.44%
13,430,456 $582 Million
Q4 2023

Feb 14, 2024

SELL
$43.39 - $51.63 $13 Million - $15.4 Million
-298,544 Reduced 2.06%
14,203,481 $719 Million
Q3 2023

Nov 14, 2023

SELL
$38.5 - $47.13 $817,778 - $1 Million
-21,241 Reduced 0.15%
14,502,025 $658 Million
Q2 2023

Aug 14, 2023

BUY
$34.73 - $43.33 $19 Million - $23.7 Million
547,476 Added 3.92%
14,523,266 $596 Million
Q1 2023

May 15, 2023

BUY
$33.58 - $41.2 $14.4 Million - $17.7 Million
429,096 Added 3.17%
13,975,790 $499 Million
Q4 2022

Feb 10, 2023

BUY
$37.12 - $46.52 $27.5 Million - $34.5 Million
740,671 Added 5.78%
13,546,694 $512 Million
Q3 2022

Nov 14, 2022

BUY
$36.54 - $48.66 $22.1 Million - $29.5 Million
605,747 Added 4.97%
12,806,023 $566 Million
Q2 2022

Aug 12, 2022

BUY
$31.71 - $43.0 $3.21 Million - $4.35 Million
101,242 Added 0.84%
12,200,276 $452 Million
Q1 2022

May 13, 2022

BUY
$29.88 - $37.04 $2.75 Million - $3.41 Million
91,958 Added 0.77%
12,099,034 $448 Million
Q4 2021

Feb 14, 2022

BUY
$25.61 - $35.1 $5.3 Million - $7.27 Million
207,067 Added 1.75%
12,007,076 $365 Million
Q3 2021

Nov 12, 2021

SELL
$33.54 - $40.55 $28.7 Million - $34.7 Million
-855,820 Reduced 6.76%
11,800,009 $396 Million
Q2 2021

Aug 13, 2021

BUY
$34.54 - $47.25 $437 Million - $598 Million
12,655,829 New
12,655,829 $505 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.33B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.